| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/12/2004 | WO2004067723A2 Floral development genes |
| 08/12/2004 | WO2004067719A2 Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals |
| 08/12/2004 | WO2004067718A2 Necrosis-deficient mutants of tuberculosis bacteria |
| 08/12/2004 | WO2004067717A2 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 08/12/2004 | WO2004067716A2 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer |
| 08/12/2004 | WO2004067712A2 Intracellular signaling molecules |
| 08/12/2004 | WO2004067711A2 Peroxisome proliferator-activated receptor |
| 08/12/2004 | WO2004067709A2 Identification of essential genes of aspergillus fumigatus and methods of use |
| 08/12/2004 | WO2004067707A2 Administration of transposon-based vectors to reproductive organs |
| 08/12/2004 | WO2004067706A2 Production of multimeric proteins |
| 08/12/2004 | WO2004067704A2 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | WO2004067698A2 Helminth-derived antigens having capacity of providing protection against parasites |
| 08/12/2004 | WO2004067695A1 Process and device for preparing phycoerythrin with high od ratio |
| 08/12/2004 | WO2004067570A2 Prostate cancer diagnosis and treatment |
| 08/12/2004 | WO2004067566A1 Factor viii polypeptide |
| 08/12/2004 | WO2004067565A1 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same |
| 08/12/2004 | WO2004067564A2 Compositions against cancer antigen liv-1 and uses thereof |
| 08/12/2004 | WO2004067563A1 Peptide inhibitors of toxins derived from ll-37 |
| 08/12/2004 | WO2004067562A1 Human protooncogene and protein encoded therein |
| 08/12/2004 | WO2004067561A1 Amyloid-$g(b)(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 08/12/2004 | WO2004067560A2 Herpes simplex vp16 protein binding polypeptides |
| 08/12/2004 | WO2004067556A1 Method for protein isolation in anoxic conditions |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004067549A2 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 08/12/2004 | WO2004067548A2 Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| 08/12/2004 | WO2004067040A1 Gene vaccine against intracellular parasite |
| 08/12/2004 | WO2004067032A2 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes |
| 08/12/2004 | WO2004067030A2 Injectable vaccines against multiple meningococcal serogroups |
| 08/12/2004 | WO2004067026A1 Regulation of allergen induced gene |
| 08/12/2004 | WO2004067025A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | WO2004067023A2 Survivin-derived peptides and use thereof |
| 08/12/2004 | WO2004067020A1 Dna vaccine composition with enhanced immunogenicity |
| 08/12/2004 | WO2004066966A2 Peptide yy analogs |
| 08/12/2004 | WO2004066958A2 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 08/12/2004 | WO2004066953A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 08/12/2004 | WO2004066948A2 Mapcaxs as modifiers of the apc and axin pathways and methods of use |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066917A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/12/2004 | WO2004066915A2 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004056969A3 Generation of plants with altered oil content |
| 08/12/2004 | WO2004056858A3 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 08/12/2004 | WO2004056347A3 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 08/12/2004 | WO2004054969A3 Sacromastigophoric therapeutic agent delivery system |
| 08/12/2004 | WO2004053137A3 Method for protein production |
| 08/12/2004 | WO2004053061A8 Methods of therapy and diagnosis using targeting of cells that express lax |
| 08/12/2004 | WO2004052392A3 Cancer immunotherapy using polycomb proteins |
| 08/12/2004 | WO2004046166A3 Modified alpha-msh peptides and derivatives thereof |
| 08/12/2004 | WO2004043999A3 Hsan ii related gene and expression products and uses thereof |
| 08/12/2004 | WO2004043563A3 Methods of isolation of active compounds and activated targets |
| 08/12/2004 | WO2004043145A3 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 08/12/2004 | WO2004041182A3 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 08/12/2004 | WO2004037998A3 Natural promoters for gene expression in c1 metabolizing bacteria |
| 08/12/2004 | WO2004033639A3 Targeting of herpes simplex virus to specific receptors |
| 08/12/2004 | WO2004032860A3 Hiv vaccine formulations |
| 08/12/2004 | WO2004032789A3 Liposomal hgh composition and method for administration thereof |
| 08/12/2004 | WO2004029201A3 Peptide derivative fusion inhibitors of hiv infection |
| 08/12/2004 | WO2004029074A3 Hiv-derived hr1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 08/12/2004 | WO2004029073A3 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 08/12/2004 | WO2004026895A3 Gd2 ligands |
| 08/12/2004 | WO2004016222A3 Hepatitis c viral-like particle purification |
| 08/12/2004 | WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 08/12/2004 | WO2004013304A3 Sugar and lipid metabolism regulators in plants iv |
| 08/12/2004 | WO2004013289A9 Diagnosis of kidney damage and protection against same |
| 08/12/2004 | WO2004007678A3 Codon optimized synthetic plasmids |
| 08/12/2004 | WO2004006857A3 Glanders/meliodosis vaccines |
| 08/12/2004 | WO2003103592A3 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003057825A3 Gene expression patterns in response to atypical and typical neuroleptic agents in the central nervous system |
| 08/12/2004 | WO2003048767B1 Use of elavl-1 gene in the detection and modulation of apoptosis |
| 08/12/2004 | WO2003042693A3 Method for measuring intracellular atp and/or gene expression |
| 08/12/2004 | WO2003039484A3 Novel compositions and methods for cancer |
| 08/12/2004 | WO2003039441A3 Unc-13 in the modulation of neurotransmission and secretion events |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | WO2002071927A9 Diagnosis and treatment of skeletal degeneration conditions |
| 08/12/2004 | WO2002059299A9 Expression cloning method |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | US20040158893 Transgenic plants comprising nucleotide sequences coding kinesin products for increasing germ cell ploidy; hybrid crop plants |
| 08/12/2004 | US20040158892 Comprises anther specific regulatory sequences for use as control agents for expression of heterologous nucleotide sequences in plants; disease resistant plants |
| 08/12/2004 | US20040158888 Nucleic acids coding retoviral regulatory sequences for use as tools in generation of transgenic seeds for propagatgion of disease, heat, herbicide and drought resistant plants |
| 08/12/2004 | US20040158884 Transgenic mouse having conditional knock-out of myostatin function |
| 08/12/2004 | US20040158883 Animal model for identification of modulators and treatments of obsessive-compulsive (OCD), attention deficit/hyperactivity (ADHD), mood, learning and sleep disorders |
| 08/12/2004 | US20040158879 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 08/12/2004 | US20040158173 Transmission assembly for a surgical biopsy device |
| 08/12/2004 | US20040158053 Plasmid comprising nucleotide sequences coding antigenic proteins for use in prevention and treatment of infectious and neoplastic diseases; gene therapy |
| 08/12/2004 | US20040158047 Method for producing cobalt-protein complex |
| 08/12/2004 | US20040158046 Modified growth hormone |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040158041 Chemically modified G-CSF |
| 08/12/2004 | US20040158040 Peptides participating in prionization of heterogenous erf3 |
| 08/12/2004 | US20040158039 Secreted proteins |
| 08/12/2004 | US20040158037 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith |
| 08/12/2004 | US20040158036 Neuritogenic compound and uses thereof |
| 08/12/2004 | US20040157792 antigen presenting cells (APCs) that express apoptosis inducing ligands and processed viral vector antigens are utilized to directly induce apoptosis of T-cells expressing the ligand receptor resulting in vector-specific T-cell tolerance |
| 08/12/2004 | US20040157781 Peptide binding the KLVFF-sequence of amyloid-beta |